Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
011516X vs Systane Ultra in Dry Eye Disease
NCT04393441Phase 3Completed
- Sponsor
- Allergan
- Start
- Jun 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 011516X in dry eye disease (DED), sponsored by Allergan. Started Jun 2020; status: completed.
02
Drugs
011516X
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04393441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04393441.